TITLE

excipient

PUB. DATE
January 2009
SOURCE
Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p821
SOURCE TYPE
Book
DOC. TYPE
Reference Entry
ABSTRACT
A definition of the term "excipient," which refers to a substance included to a drug, is presented.
ACCESSION #
62143321

 

Related Articles

  • povidone.  // Taber's Cyclopedic Medical Dictionary;2005, p1747 

    The article presents a definition for the term "povidone," which refers to a synthetic polymer used as a dispersing and suspending agent in manufacturing drugs.

  • excipient.  // Taber's Cyclopedic Medical Dictionary;2005, p752 

    A definition of the medical term "excipient" is presented. Excipient refers to any substance added to a medicine so that it can be formed into the proper shape and consistency. The term originated from the word "excipiens" which means excepting. The definition is from the "Taber's Cyclopedic...

  • Sweeteners, dyes, and other excipients in vitamin and mineral preparations. Kumar, Ashir; Aitas, Anastassios T. // Clinical Pediatrics;Sep1996, Vol. 35 Issue 9, p443 

    Presents a study on excipients in vitamin and mineral preparations. Excipient information in product packages; Adverse effects; Proposal for the mandatory listing of all excipients.

  • Market pressures drive excipients. Walsh, Kerri A. // Chemical Week;4/16/1997, Vol. 159 Issue 15, p30 

    Reports on the active market of inert pharmaceutical ingredients known as excipients. Projected excipient market growth in the United States; Comments of FMC company executive Mike DeCola; Producers' comments on meeting customers' demand and Food and Drug Administration's guidelines; Definition...

  • Excipients. J.W. // Chemical Market Reporter;09/15/97, Vol. 252 Issue 11, Pharmaceuticals... p18 

    Focuses on the increasing use of excipients around the world. Value of the worldwide specialty excipient market; Role of excipients in facilitating the absorption of certain drugs; Trend toward using synthetic excipients; Changing standards for excipients.

  • Vigilance: The Active Ingredient in Excipient Product Security. MacRae, Michael // Pharmaceutical Technology North America;Jun2002, Vol. 26 Issue 6, p110 

    Comments on issues about product security and the prevention of product tampering in excipient manufacturing and product delivery cycle in the U.S. Reduction of the risk of contamination; Inspection of the incoming and outgoing transportation system; Factors affecting bioterrorism prevention.

  • EMD Millipore Introduces Parteck SLC.  // Contract Pharma;Nov/Dec2013, Vol. 15 Issue 9, p93 

    Information on Parteck SLC, a new excipient that delivers increased loadability for active pharmaceutical ingredients, from Md Millipore, the Life Science Division of Merck KGAA, is presented.

  • Tetracycline.  // Reactions Weekly;10/8/2011, Issue 1372, p33 

    The article describes the case of a 19-year-old woman who ptosis and periorbital oedema with firm yellowish lesions in both eyelids possibly due to petrolatum and mineral oil excipients.

  • Objectives, Challenges, and Progress in The Global Harmonization of Excipient Monographs. Shaheen, Victoria // Pharmaceutical Technology;Jun2003, Vol. 27 Issue 6, p40 

    Reports on the International Pharmaceutical Excipient Councils' (IPEC) coordination of efforts with global regulatory agencies on an initiative to construct comprehensive monographs for key excipients that will satisfy the American, Japanese and European pharmacopeias. Condition when a...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics